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Introduction
The 2010 Global Burden of Disease (GBD) 
study surprised many by reporting that 
drinking water quality was not a risk factor 
for diarrheal disease (Lim et al. 2012). 
Its conclusion was based on the generally 
accepted preference for blinded trials over 
trials following nonblinded or open study 
designs (Clasen et al. 2015). Researchers 
assembled by the World Health Organization 
(WHO) responded promptly. Although 
they acknowledged the disparity between 
results based on study design, they opted 
to pool results from all studies, blinded and 
open, citing shortcomings from some of 
the blinded studies (Wolf et al. 2014). This 
yielded an overall protective effect, restoring 
safe drinking water as a priority in public 
health. Recently, the 2013 GBD study used 
the results from the WHO-sponsored review 
with no explanation about why it reversed 
its previous reliance on blinded trials only 
(GBD 2013 Risk Factors Collaborators 
et al. 2015).
Double-blinded, randomized, placebo-
controlled trials where both the subject and 
investigator are unaware of whether the 
subject is a member of the intervention or 
control group are often cited as the “gold 
standard” for epidemiological evidence, 
offering high potential for causal inference. 
Assuming the generation and concealment of 
the allocation sequence and other protections, 
random allocation of study subjects minimizes 
the risk of selection bias, and blinding reduces 
the risk of reporting bias (single blinded) and 
measurement bias (double or triple blinded).
Although double-blinded, random-
ized controlled trials (RCTs) are common 
in drug trials where inert agents can often 
be formulated, packaged, and presented as 
placebos, blinding at the participant level can 
be difficult or impossible in the case of basic 
environmental health interventions, such 
as improved water supplies, sanitation, and 
hygiene (WASH) (Allen et al. 2015).
Among WASH interventions, blinding has 
been attempted only for household water treat-
ment (HWT) interventions designed to assess 
the health impact of improved drinking water 
quality. To date, a total of 10 blinded studies 
have been reported, 4 comparing home-based 
chlorine with a placebo (Austin 1993; Boisson 
et al. 2013; Jain et al. 2010; Kirchhoff et al. 
1985) and 6 comparing a plumbed-in or 
table-top household water filter with a sham 
filter (Boisson et al. 2010; Colford et al. 2002, 
2005, 2009; Hellard et al. 2001; Rodrigo et al. 
2011). Half of the trials were conducted in 
low-income settings with water shown to be 
fecally contaminated (Austin 1993; Boisson 
et al. 2010, 2013; Jain et al. 2010; Kirchhoff 
et al. 1985), whereas the balance took place 
in high-income countries with water shown 
or presumed to meet international standards. 
Poor adherence may have also contributed to a 
lack of effect (Clasen et al. 2015).
Significantly, although trials of HWT 
interventions that follow open study designs 
have reported large and fairly consistent protec-
tive effects on diarrhea, only one blinded 
trial has reported the intervention to prevent 
the disease (Colford et al. 2009). In a recent 
systematic review and meta-analysis of these 
studies, the pooled estimate of effect from 
open-trial designs yielded a relative risk of 
diarrhea of 0.55 [95% confidence interval (CI): 
0.44, 0.68; 46 comparisons], whereas that from 
blinded trials was 0.94 (95% CI: 0.84, 1.06; 
10 analyses) (Clasen et al. 2015). Though 
questions were raised about compliance and 
ambient risk, the review concluded that the 
blinded trials presented little risk of bias.
This disparity in results between open 
and blinded trials has important questions 
that are still the subject of much debate in the 
WASH sector. Some focused specifically on 
HWT, arguing that that the evidence does 
not support efforts to scale up the interven-
tion (Schmidt and Cairncross 2009). Others 
extended the results to water quality inter-
ventions generally, concluding that water 
quality is not a risk factor in the global burden 
of disease (Engell and Lim 2013; Lim et al. 
2012). Still others have generalized the results 
to all nonblinded studies of household-level 
WASH interventions. This has led to the 
conclusion that, after adjusting for the bias 
due to nonblinding, hygiene interventions 
are not effective against diarrhea (Freeman 
et al. 2014).
In our most recent trials of HWT inter-
ventions, we used placebos to minimize 
the risk of reporting bias. A trial in the 
Democratic Republic of the Congo (DRC) 
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where a sham filter shown to have no effect 
in the lab actually removed 90% of fecal indi-
cator bacteria in the field (probably due to 
accumulated biofilm) demonstrated the chal-
lenge of implementing a neutral placebo in the 
case of a filter (Boisson et al. 2010). However, 
our trial of a chlorine intervention in India 
raised potentially more fundamental questions 
about the ethics of blinding trials of WASH 
interventions in low-income settings (Boisson 
et al. 2013).
The India trial sought to assess the 
impact of an intervention consisting of the 
free distribution of sodium dichloroisocyan-
urate (NaDCC) tablets and the promotion 
of their use in bi-monthly household visits 
(Boisson et al. 2013). NaDCC tablets have 
long been used for the emergency treatment 
of water and more recently for the routine 
treatment of drinking water. This product 
was selected for the intervention because 
chlorine is widely used for water treatment 
and because a previous study reported that 
blinding of NaDCC tablets was feasible (Jain 
et al. 2010). The study was conducted in the 
State of Orissa among 11 informal settle-
ments in the capital city of Bhubaneswar and 
20 rural villages in the district of Dhenkanal. 
Most households rely on water from poorly 
protected open hand-dug wells, or from yard 
or public taps connected to a distribution 
system drawing from wells. At baseline, 30% 
of households reported treating their water at 
home, two-thirds of these by boiling.
During enrollment, we sought to have 
study participants understand the nature of a 
placebo and the risks of discontinuing poten-
tially effective water management practices. 
We explained that half of study households 
would be receiving a tablet that would have 
no impact on water quality, and that it was 
unlikely that they would be able to tell the 
active from the inactive tablet. We encour-
aged householders to continue their existing 
water treatment practices throughout the 
duration of the trial even if they thought 
they were receiving the active disinfectant. 
Enumerators reinforced that message during 
subsequent household visits.
Despite those recommendations and 
reminders, Figure 1 shows that some 
study households gradually switched from 
boiling to use of the tablets. At the end of 
the 12-month trial, self-reported boiling 
decreased by about one-third.
Discussion
The decision to switch from boiling to use of 
tablets may have been attributable to partici-
pants’ belief that they were part of the inter-
vention arm using active NaDCC tablets. 
In a post-trial assessment of the effectiveness 
of blinding, the overwhelming majority of 
both study arms guessed that they had been 
assigned to the intervention group (71.5% 
of intervention group members and 71.2% 
of control group); only 2.5% of intervention 
group members and 3.7% of control group 
members guessed that they were part of the 
control group (Boisson et al. 2013). Other 
trials that have reported on the effective-
ness of blinding have also found that most 
study participants (including control group 
members) believed they had the active inter-
vention (Boisson et al. 2010; Colford et al. 
2002, 2009; Jain et al. 2010).
The continuing uncertainty over the 
effectiveness of water quality interventions 
satisfies the basic ethics requirement of 
equipoise in research. However, additional 
protections are imposed in the case of 
placebo-controlled trials. According to the 
Helsinki Declaration (http://www.wma.net/
en/30publications/10policies/b3/), unless the 
placebo represents the “best proven inter-
vention” (i.e., standard of care), a placebo-
controlled trial may be undertaken only 
where “for compelling and scientifically sound 
methodological reasons the use of placebo is 
necessary to determine the efficacy or safety of 
an intervention and the patients who receive 
placebo or no treatment will not be subject 
to any risk of serious or irreversible harm.” 
Although our results from India are not 
dispositive, they suggest that members of the 
control group were indeed put at increased 
risk as a result of discontinuing boiling their 
water in favor of using the placebo.
The potential for increased risk to the 
control group raises serious questions about 
the continued use of a placebo to assess 
HWT interventions, at least in settings 
where the water presents known risks and 
in which members of study population are 
reported to be practicing a potentially effec-
tive alternative such as boiling. Because 
evidence suggests that most participants in 
blinded HWT trials believe they have been 
assigned to the active intervention group, it 
is not clear that this risk could be mitigated 
even by carefully cautioning participants to 
continue their water management practices 
or reinforcing this message throughout the 
trial. Such close monitoring may engender 
reactivity that could undermine study validity 
(Zwane et al. 2011). It is also unlikely that 
risks for waterborne disease could be managed 
through normal surveillance and referral of 
cases for treatment.
We emphasize that discontinued practice 
of a potentially protective behavior by the 
control group does not affect the validity of 
placebo-controlled trials or their potential 
to estimate the effect of the intervention. 
Nevertheless, the ethical issues presented 
should limit the circumstances in which 
researchers may undertake placebo-controlled 
trials of water quality interventions when 
researchers cannot be sure that members of 
the control group will not be put at increased 
risk. At the same time, they should encourage 
further research to improve the reliability of 
outcomes in open trial designs.
One approach is to attempt to adjust 
results for lack of blinding at the partici-
pant level. Recent systematic reviews have 
shown that the nonblinded trials with subjec-
tive outcomes may exaggerate effectiveness 
by around 30% compared to blinded trials 
(Savović et al. 2012). These results have been 
used in other reviews of WASH interven-
tions to adjust pooled estimates of effect 
(Wolf et al. 2014). The adjustment, however, 
is derived mainly from clinical studies of 
drug therapies. It is unclear whether the same 
discount can be applied to field trials of water 
quality and other WASH interventions or 
that the adjustment would be homogenous 
across different populations, interventions, 
and data collection methods.
Another approach is to exclude house-
holds that treat their water (or practice 
Figure 1. Reported use of tablets and boiling over the 12-month follow-up period (n = 22,884 visits).
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a relevant WASH behavior) as part of the 
study’s eligibility criteria. This presents at least 
three problems. First, identifying those that 
actually practice the behavior is challenging, 
both because of courtesy and social desir-
ability bias (exaggerating the practice) and 
the tendency to misreport in order to qualify 
for study participation. Second, householders 
exaggerate the consistency of environmental 
behaviors such as treating their drinking 
water or collecting it from safe sources (Rosa 
et al. 2014). Third, excluding self-reported 
practitioners of these behaviors limits the 
potential of these studies to estimate larger 
 population effects.
Perhaps the best alternative to blinding at 
the study participant level is to use objective 
outcomes. Studies have evaluated the effec-
tiveness of HWT and other WASH interven-
tions by assaying stools for enteric pathogens 
or blood for seroconversion to waterborne 
pathogens (Crump et al. 2007; Mahfouz et al. 
1995; Quick et al. 1999). More recent studies 
include potential biomarkers such as inflam-
matory cytokines or markers of intestinal 
dysfunction, including environmental enter-
opathy (Arnold et al. 2013). One-step immu-
nochromatographic dipstick tests have been 
successfully developed for cholera (Nato et al. 
2003) and various Shigella species (Duran 
et al. 2013). A “lab-on-a-card” diagnostic tool 
against a broader range of infectious agents 
responsible for pneumonia and diarrhea—the 
major killers of young children in low-income 
countries—would have obvious clinical value. 
Other studies have used anthropometry—a 
potential marker of recent (weight-for-age) 
or longer-term (stunting) enteric infection. 
Three studies assessed weight-for-age, a poten-
tial proxy for acute diarrhea in HWT trials 
(Boisson et al. 2013; du Preez et al. 2011; 
Peletz et al. 2012); others have used anthro-
pometry to assess the health impact of sanita-
tion (Arnold et al. 2010; Clasen et al. 2014; 
Patil et al. 2014). However, caution must 
be exercised to ensure the objectivity of this 
metric (Arnold et al. 2012). Other studies 
have attempted to minimize bias by using 
clinical records of morbidity and mortality 
(Mahfouz et al. 1995).
None of the existing objective metrics, 
however, are wholly satisfactory, especially 
for evaluating large-scale programs involving 
WASH interventions. Assays of stools are 
costly and intrusive, and often are unable to 
incriminate pathogens. Blood draws for sero-
conversion studies are also intrusive and often 
inconclusive even in children in low-income 
settings where seroprevalence is high even at 
an early age. The value of anthropometry to 
assess WASH interventions is still unclear. 
And reliance on clinical records typically 
requires much larger sample sizes, and these 
are subject to other sources of systematic bias.
Conclusion
Water quality and other WASH interven-
tions have the potential to significantly 
reduce the burden of disease associated with 
enteric pathogens. There is an ongoing need, 
however, to rigorously assess their effectiveness 
in order to optimize programmatic interven-
tions. Our results suggest that blinding trials 
at the participant level by using placebos in 
settings where some participants may already 
be practicing protective measures may increase 
the risk of exposure among study participants. 
There may be cases in which researchers can 
manage this risk without causing reactivity or 
otherwise affecting the integrity of the study. 
Alternative approaches are needed, including 
the development and validation of objec-
tive metrics that are reliable, affordable, and 
suitable both for research and the monitoring 
and evaluation of WASH programs.
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